KERNW

Akerna Corp. KERNW

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode KERNW BLPH ATLN SEEL VIRI MSPR CMAX TCBP HSTO HUGE
6M -95.30 % -76.47 % 45.00 % -97.25 % -98.50 % -99.07 % 421 400.01 % -99.38 % -93.33 % -99.82 %
YTD -96.07 % 0.00 % 27.94 % -99.79 % -98.94 % -33.22 % 1 586.00 % -94.85 % -93.55 % -99.85 %
1Y -99.00 % -81.27 % -53.14 % -99.82 % -99.11 % -99.61 % 1 363.54 % -99.80 % -93.73 % -99.90 %
3Y -99.92 % -99.57 % -83.27 % -99.99 % -99.89 % -99.63 % -99.58 % -100.00 % -99.71 % -99.92 %
5Y -99.96 % -99.79 % -98.56 % -99.99 % -99.96 % -99.63 % -99.91 % -100.00 % -99.97 % -99.99 %
10Y -99.96 % -99.99 % -98.56 % -100.00 % -99.96 % -99.63 % -99.86 % -100.00 % -100.00 % -99.99 %
From the beginning -99.96 % -99.99 % -98.56 % -100.00 % -99.96 % -99.63 % -99.86 % -100.00 % -100.00 % -99.99 %

Dividend

Bellerophon Therapeutics, Inc.